The drug, HU-308, lessens involuntary movements called dyskinesias, a side effect from years of treatment for Parkinson's disease

Rutgers innovation may help guide treatment of Alzheimer's, Parkinson's diseases

Study reveals crucial role of alpha-synuclein protein in DNA repair

Experiments in mice show transmission of nerve-killing protein from the gut into the brain

Researchers believe an enzyme targeted to the neuronal mitochondria may be responsible for converting compounds from alcohol, tobacco, and certain foods into chemicals that trigger or advance the disease

A novel gene therapy approach blocks the accumulation of α-synuclein in the brain, preventing the development of Parkinson's disease

Scientists developed a technique for brain training capable to induce changes of neural networks in less than one hour

Virtual reality games could help individuals with certain neurological conditions shift their perceptions of time

Scientists evaluate promising research hypotheses for understanding environmental triggers in Parkinson’s disease